Concepedia

Anna Elinder Camburn

AE

Statistics

Publications

3

Citations

35

H-Index

3

Active since

2019

Affiliations

North Shore Hospital(Current)

Weill Cornell Medicine

St Vincent's Hospital Melbourne

University of California, Irvine

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Anna Elinder Camburn is an author at North Shore Hospital specializing in immunology, hematology, and autoimmunity.

ORCID

Top concepts

Publications per year

2019–2025

3

Publications

3

Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes

Anna Elinder Camburn, Michelle Petrasich, Anna Ruskova et al. · Pathology · 2019 · 13 citations

, , +6

Outcomes in high-risk subgroups after fixed-duration ibrutinib + venetoclax for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): Up to 5.5 years of follow-up in the phase 2 CAPTIVATE study.

William G. Wierda, Ryan Jacobs, Paul M. Barr et al. · Journal of Clinical Oncology · 2024 · 12 citations · Full text

Final analysis of fixed-duration ibrutinib + venetoclax for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in the phase 2 CAPTIVATE study.

Paolo Ghia, Paul M. Barr, John N. Allan et al. · Journal of Clinical Oncology · 2025 · 10 citations · Full text

1–3 of 3